{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T11:50:41Z","timestamp":1793015441342,"version":"4.5.0"},"reference-count":35,"publisher":"American Medical Association (AMA)","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Oncol"],"DOI":"10.1001\/jamaoncol.2020.7987","type":"journal-article","created":{"date-parts":[[2021,2,25]],"date-time":"2021-02-25T12:41:26Z","timestamp":1614256886000},"source":"Crossref","is-referenced-by-count":43,"title":["Assessment of Clinical Benefit of Integrative Genomic Profiling in Advanced Solid Tumors"],"prefix":"10.1001","author":[{"given":"Erin F.","family":"Cobain","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, University of Michigan, Ann Arbor"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Mi","family":"Wu","sequence":"additional","affiliation":[{"name":"Michigan Center for Translational Pathology, University of Michigan, Ann Arbor"},{"name":"Department of Pathology, University of Michigan, Ann Arbor"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pankaj","family":"Vats","sequence":"additional","affiliation":[{"name":"Michigan Center for Translational Pathology, University of Michigan, Ann Arbor"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rashmi","family":"Chugh","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of Michigan, Ann Arbor"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis","family":"Worden","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of Michigan, Ann Arbor"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David C.","family":"Smith","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of Michigan, Ann Arbor"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott M.","family":"Schuetze","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of Michigan, Ann Arbor"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark M.","family":"Zalupski","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of Michigan, Ann Arbor"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vaibhav","family":"Sahai","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of Michigan, Ann Arbor"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajjai","family":"Alva","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of Michigan, Ann Arbor"},{"name":"Michigan Center for Translational Pathology, University of Michigan, Ann Arbor"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne F.","family":"Schott","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of Michigan, Ann Arbor"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan E. V.","family":"Caram","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of Michigan, Ann Arbor"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel F.","family":"Hayes","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of Michigan, Ann Arbor"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena M.","family":"Stoffel","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of Michigan, Ann Arbor"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle F.","family":"Jacobs","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of Michigan, Ann Arbor"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chandan","family":"Kumar-Sinha","sequence":"additional","affiliation":[{"name":"Michigan Center for Translational Pathology, University of Michigan, Ann Arbor"},{"name":"Department of Pathology, University of Michigan, Ann Arbor"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuhong","family":"Cao","sequence":"additional","affiliation":[{"name":"Michigan Center for Translational Pathology, University of Michigan, Ann Arbor"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Wang","sequence":"additional","affiliation":[{"name":"Michigan Center for Translational Pathology, University of Michigan, Ann Arbor"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Lucas","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Michigan, Ann Arbor"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Ning","sequence":"additional","affiliation":[{"name":"Michigan Center for Translational Pathology, University of Michigan, Ann Arbor"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica","family":"Rabban","sequence":"additional","affiliation":[{"name":"Michigan Center for Translational Pathology, University of Michigan, Ann Arbor"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janice","family":"Bell","sequence":"additional","affiliation":[{"name":"Michigan Center for Translational Pathology, University of Michigan, Ann Arbor"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Camelo-Piragua","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Michigan, Ann Arbor"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron M.","family":"Udager","sequence":"additional","affiliation":[{"name":"Michigan Center for Translational Pathology, University of Michigan, Ann Arbor"},{"name":"Department of Pathology, University of Michigan, Ann Arbor"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcin","family":"Cieslik","sequence":"additional","affiliation":[{"name":"Michigan Center for Translational Pathology, University of Michigan, Ann Arbor"},{"name":"Department of Pathology, University of Michigan, Ann Arbor"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Lonigro","sequence":"additional","affiliation":[{"name":"Michigan Center for Translational Pathology, University of Michigan, Ann Arbor"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lakshmi P.","family":"Kunju","sequence":"additional","affiliation":[{"name":"Michigan Center for Translational Pathology, University of Michigan, Ann Arbor"},{"name":"Department of Pathology, University of Michigan, Ann Arbor"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan R.","family":"Robinson","sequence":"additional","affiliation":[{"name":"Michigan Center for Translational Pathology, University of Michigan, Ann Arbor"},{"name":"Department of Pathology, University of Michigan, Ann Arbor"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moshe","family":"Talpaz","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of Michigan, Ann Arbor"},{"name":"Rogel Cancer Center, University of Michigan, Ann Arbor"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arul M.","family":"Chinnaiyan","sequence":"additional","affiliation":[{"name":"Michigan Center for Translational Pathology, University of Michigan, Ann Arbor"},{"name":"Department of Pathology, University of Michigan, Ann Arbor"},{"name":"Rogel Cancer Center, University of Michigan, Ann Arbor"},{"name":"Department of Urology, University of Michigan, Ann Arbor"},{"name":"Howard Hughes Medical Institute, University of Michigan, Ann Arbor"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2021,2,25]]},"reference":[{"issue":"1","key":"coi200115r1","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1056\/NEJMoa1913662","article-title":"Overall survival with osimertinib in untreated, EGFR-mutated advanced NSCLC.","volume":"382","author":"Ramalingam","year":"2020","journal-title":"N Engl J Med"},{"issue":"11","key":"coi200115r2","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1056\/NEJM200103153441101","article-title":"Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.","volume":"344","author":"Slamon","year":"2001","journal-title":"N Engl J Med"},{"issue":"1","key":"coi200115r3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1200\/JCO.19.02105","article-title":"Efficacy of pembrolizumab in patients with noncolorectal high microsatellite instability\/mismatch repair-deficient cancer: results from the phase II KEYNOTE-158 study.","volume":"38","author":"Marabelle","year":"2020","journal-title":"J Clin Oncol"},{"issue":"18","key":"coi200115r4","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1056\/NEJMoa1210093","article-title":"Combined BRAF and MEK inhibition in melanoma with BRAF V600 mutations.","volume":"367","author":"Flaherty","year":"2012","journal-title":"N Engl J Med"},{"issue":"6349","key":"coi200115r5","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1126\/science.aan6733","article-title":"Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade.","volume":"357","author":"Le","year":"2017","journal-title":"Science"},{"issue":"4","key":"coi200115r6","article-title":"Trastuzumab containing regimens for early breast cancer.","author":"Moja","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"coi200115r7","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1056\/NEJMoa1713137","article-title":"Osimertinib in untreated EGFR-mutated advanced non\u2013small-cell lung cancer.","volume":"378","author":"Soria","year":"2018","journal-title":"N Engl J Med"},{"issue":"4","key":"coi200115r8","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1001\/jamaoncol.2015.1313","article-title":"Whole-exome sequencing of metastatic cancer and biomarkers of treatment response.","volume":"1","author":"Beltran","year":"2015","journal-title":"JAMA Oncol"},{"issue":"11","key":"coi200115r9","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1038\/nbt.2696","article-title":"Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing.","volume":"31","author":"Frampton","year":"2013","journal-title":"Nat Biotechnol"},{"issue":"25","key":"coi200115r10","doi-asserted-by":"publisher","first-page":"2753","DOI":"10.1200\/JCO.2014.60.4165","article-title":"Feasibility of large-scale genomic testing to facilitate enrollment onto genomically matched clinical trials.","volume":"33","author":"Meric-Bernstam","year":"2015","journal-title":"J Clin Oncol"},{"issue":"35","key":"coi200115r11","doi-asserted-by":"publisher","first-page":"56491","DOI":"10.18632\/oncotarget.v7i35","article-title":"Clinical benefit of a precision medicine based approach for guiding treatment of refractory cancers.","volume":"7","author":"Radovich","year":"2016","journal-title":"Oncotarget"},{"issue":"7667","key":"coi200115r12","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1038\/nature23306","article-title":"Integrative clinical genomics of metastatic cancer.","volume":"548","author":"Robinson","year":"2017","journal-title":"Nature"},{"issue":"6","key":"coi200115r13","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1158\/1535-7163.MCT-14-1061","article-title":"On the road to precision cancer medicine: analysis of genomic biomarker actionability in 439 patients.","volume":"14","author":"Schwaederle","year":"2015","journal-title":"Mol Cancer Ther"},{"issue":"19","key":"coi200115r14","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.87062","article-title":"Institutional implementation of clinical tumor profiling on an unselected cancer population.","volume":"1","author":"Sholl","year":"2016","journal-title":"JCI Insight"},{"issue":"4","key":"coi200115r15","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1158\/1078-0432.CCR-18-1780","article-title":"Copenhagen Prospective Personalized Oncology (CoPPO)\u2014clinical utility of using molecular profiling to select patients to phase I trials.","volume":"25","author":"Tuxen","year":"2019","journal-title":"Clin Cancer Res"},{"issue":"6","key":"coi200115r16","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1038\/nm.4333","article-title":"Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients.","volume":"23","author":"Zehir","year":"2017","journal-title":"Nat Med"},{"issue":"4","key":"coi200115r17","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1158\/1535-7163.MCT-15-0795","article-title":"Precision oncology: the UC San Diego Moores Cancer Center PREDICT experience.","volume":"15","author":"Schwaederle","year":"2016","journal-title":"Mol Cancer Ther"},{"issue":"13","key":"coi200115r18","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1016\/S1470-2045(15)00188-6","article-title":"Molecularly targeted therapy based on tumour molecular profiling versus conventional therapy for advanced cancer (SHIVA): a multicentre, open-label, proof-of-concept, randomised, controlled phase 2 trial.","volume":"16","author":"Le Tourneau","year":"2015","journal-title":"Lancet Oncol"},{"issue":"13","key":"coi200115r19","doi-asserted-by":"publisher","first-page":"3690","DOI":"10.1158\/0008-5472.CAN-15-3043","article-title":"Cancer therapy directed by comprehensive genomic profiling: a single center study.","volume":"76","author":"Wheler","year":"2016","journal-title":"Cancer Res"},{"key":"coi200115r20","author":"Tsimberidou","year":"2017","journal-title":"JCO Precis Oncol"},{"issue":"6","key":"coi200115r21","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1158\/2159-8290.CD-16-1396","article-title":"High-throughput genomics and clinical outcome in hard-to-treat advanced cancers: results of the MOSCATO 01 trial.","volume":"7","author":"Massard","year":"2017","journal-title":"Cancer Discov"},{"issue":"18","key":"coi200115r22","doi-asserted-by":"publisher","first-page":"4827","DOI":"10.1158\/1078-0432.CCR-14-0603","article-title":"Personalized medicine for patients with advanced cancer in the phase I program at MD Anderson: validation and landmark analyses.","volume":"20","author":"Tsimberidou","year":"2014","journal-title":"Clin Cancer Res"},{"issue":"5","key":"coi200115r23","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1038\/s41591-019-0424-4","article-title":"Genomic and transcriptomic profiling expands precision cancer medicine: the WINTHER trial.","volume":"25","author":"Rodon","year":"2019","journal-title":"Nat Med"},{"issue":"111","key":"coi200115r24","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3003161","article-title":"Personalized oncology through integrative high-throughput sequencing: a pilot study.","volume":"3","author":"Roychowdhury","year":"2011","journal-title":"Sci Transl Med"},{"issue":"1","key":"coi200115r25","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.jmoldx.2016.10.002","article-title":"Standards and guidelines for the interpretation and reporting of sequence variants in cancer: a joint consensus recommendation of the Association for Molecular Pathology, American Society of Clinical Oncology, and College of American Pathologists.","volume":"19","author":"Li","year":"2017","journal-title":"J Mol Diagn"},{"issue":"10","key":"coi200115r26","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1093\/bioinformatics\/btu044","article-title":"Modeling tissue contamination to improve molecular identification of the primary tumor site of metastases.","volume":"30","author":"Vincent","year":"2014","journal-title":"Bioinformatics"},{"key":"coi200115r27","author":"Chakravarty","year":"2017","journal-title":"JCO Precis Oncol"},{"issue":"9","key":"coi200115r28","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1093\/annonc\/mdy263","article-title":"A framework to rank genomic alterations as targets for cancer precision medicine: the ESMO Scale for Clinical Actionability of Molecular Targets (ESCAT).","volume":"29","author":"Mateo","year":"2018","journal-title":"Ann Oncol"},{"issue":"4","key":"coi200115r29","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1038\/s41588-020-0603-8","article-title":"A harmonized meta-knowledgebase of clinical interpretations of somatic genomic variants in cancer.","volume":"52","author":"Wagner","year":"2020","journal-title":"Nat Genet"},{"issue":"3","key":"coi200115r30","first-page":"31","article-title":"An overview of the NCI precision medicine trials-NCI MATCH and MPACT.","volume":"4","author":"Do","year":"2015","journal-title":"Chin Clin Oncol"},{"issue":"3","key":"coi200115r31","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1053\/j.seminoncol.2014.05.002","article-title":"Molecular analysis for therapy choice: NCI MATCH.","volume":"41","author":"Conley","year":"2014","journal-title":"Semin Oncol"},{"key":"coi200115r33","author":"Mangat","year":"2018","journal-title":"JCO Precis Oncol"},{"issue":"33","key":"coi200115r35","doi-asserted-by":"publisher","first-page":"3883","DOI":"10.1200\/JCO.19.03010","article-title":"Molecular landscape and actionable alterations in a genomically guided cancer clinical trial: National Cancer Institute Molecular Analysis for Therapy Choice (NCI-MATCH).","volume":"38","author":"Flaherty","year":"2020","journal-title":"J Clin Oncol"},{"key":"coi200115r32","unstructured":"ClinicalTrials.gov. Targeted therapy directed by genetic testing in treating patients with advanced refractory solid tumors, lymphomas, or multiple myeloma (the MATCH screening trial). NCT02465060. Accessed February 4, 2020. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02465060"},{"key":"coi200115r34","unstructured":"ClinicalTrials.gov. TAPUR: testing the use of Food and Drug Administration (FDA) approved drugs that target a specific abnormality in a tumor gene in people with advanced stage cancer (TAPUR). NCT02693535. Accessed February 4, 2020. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02693535"}],"container-title":["JAMA Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaoncology\/articlepdf\/2776760\/jamaoncology_cobain_2021_oi_200115_1613574429.81704.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,25]],"date-time":"2021-02-25T12:41:45Z","timestamp":1614256905000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaoncology\/fullarticle\/2776760"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,25]]},"references-count":35,"URL":"https:\/\/doi.org\/10.1001\/jamaoncol.2020.7987","relation":{},"ISSN":["2374-2437"],"issn-type":[{"value":"2374-2437","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2,25]]}}}